Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US3847471014
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG01N6CGW43
GRAL
Grail, Inc.
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: - · THEMEFOLIO: $HLTH
NAME
Grail, Inc.
ISIN
US3847471014
TICKER
GRAL
MIC
XNAS
REUTERS
GRAL.OQ
BLOOMBERG
GRAL US
Tue, 22.04.2025       Grail Inc.
US3847471014

Real-World Data in 100,000 Patients Further Support the Galleri® Test's Ability to Simultaneously Screen for Multiple Cancers, as Well as its Accuracy of Cancer Signal of Origin Prediction to Support More Efficient Diagnostic Evaluations Data From GRAIL's ctDNA-based Targeted Methylation Assay Highlight Potential to Identify Robust Signals of Pr...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 26, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 108,450 shares of GRAIL's common stock to 15 recently hired non...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Tue, 25.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress Kate Walsh to launch Generation Possible, an educational initiative to raise awareness of multi-cancer early detection (MCED) testing. Generation P...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Fri, 21.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET. ...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Thu, 20.02.2025       Grail Inc.
US3847471014

Sold More than 137,000 Galleri® Tests in 2024, Growing U.S. Galleri Revenue 45% Year-Over-Year to $108.6 Million Completed Study Visits for Two Registrational Studies in July to Support Modular PMA Submission for Galleri On Track for Continued Commercial Growth in 2025 with TRICARE Coverage and Recent Announcement of Quest Integration Moderated...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.02.2025       Grail Inc.
US3847471014

MENLO PARK, Calif., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter 2024 following the close of market on Thursday, Feb. 20, 2025. Following the release, company management will h...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.02.2025       Grail Inc.
US3847471014

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience  MENLO PARK, Calif. and SECAUCUS, N.J., Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.01.2025       Grail Inc.
US3847471014

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, Calif., Jan. 13, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that patient-reported outcomes...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.12.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Dec. 18, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 15 at 9:00 a.m. PT. ...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Tue, 03.12.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Dec. 3, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 115,093 shares of GRAIL's common stock to 46 recently hired non-...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 19.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 19, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will participate in the following investor conferences....
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 18, 2024  /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that the first patient has been tested for eligibility with the investigational GRAIL Non-Small Cell Lung Cancer (NSCLC) ctDNA Assay in the global TROPION-Lung12 Phase 3...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.11.2024       Grail Inc.
US3847471014

Galleri Revenue Grew 52% Year-Over-Year to $25.4 Million Commercial Galleri Sales Surpassed 250,000 Tests Since Launch Cash Balance of $853.6 Million Provides Runway Into 2028 MENLO PARK, Calif., Nov. 12, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today repor...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Mon, 04.11.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.10.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Oct. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the third quarter 2024 following the close of market on Tuesday, Nov. 12, 2024. Following the release, company management will hos...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Thu, 24.10.2024       Grail Inc.
US3847471014

Study Participants from Veteran Affairs Sites Include a Diverse Population With Toxic Exposure MENLO PARK, Calif., Oct. 23, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced early results from the REFLECTION study, which aims to understand the real-...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Mon, 21.10.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Oct. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the appointment of Sarah Krevans to its Board of Directors, effective immediately. Ms. Krevans will also serve as a member of the Board's Audit Committee, Compensation Com...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.08.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Aug. 30, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units ("RSUs") underlying an aggregate of 182,223 shares of GRAIL's common stock to 55 recently hired non-e...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.08.2024       Grail Inc.
US3847471014

Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers MENLO PARK, Calif., Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings of the performance of its Galleri® multi-cancer early detect...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.08.2024       Grail Inc.
US3847471014

MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 3:20 p.m. ET on Sept. 4, 2024....
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 13.08.2024       Grail Inc.
US3847471014

Second Quarter Revenue Grew 43% Year-Over-Year to $32.0 Million Portfolio Prioritization and Corporate Restructure Extends Cash Runway into 2028 MENLO PARK, Calif., Aug. 13, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial resu...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Thu, 08.08.2024       Grail Inc.
US3847471014

Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom ATLANTA, Aug. 8, 2024 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE: UP) today announced that Gregory L. Summe, Managing Partner of Glen Capital Partners LLC, joined its Board of Directors, effective August 7....
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink
Wed, 10.07.2024       Grail Inc.
US3847471014

Das Instrument NL0 US3847471014 GRAIL INC. DL-,01 EQUITY hat seinen ersten Handelstag am 11.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N The instrument NL0 US3847471014 GRAIL INC. DL-,01 EQUITY has its first trading date on 11.07.2024: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
Read more
Grail Inc.
Technical Analysis Termsheets Terminal
Permalink